By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Health Discovery Corporation today announced it has filed a request for the reexamination of a patent held by Intel with applications for the identification of disease genes.

The request to the US Patent and Trademark Office challenges US Patent No. 7,685,077, which grants Intel the rights to the RFE-SVM method as described in the patent entitled, "Recursive Feature Eliminating Method Based on a Support Vector Machine."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.